News | December 12, 2025
Alembic receives USFDA final approval for Loteprednol Etabonate and Tobramycin Ophthalmic suspension
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Zylet Ophthalmic Suspension, 0.5%/0.3%, of Bausch & Lomb
